TY - JOUR AU - Levy, M. M. AU - Evans, L. E. AU - Rhodes, A. PY - 2018 DA - 2018// TI - The surviving sepsis campaign bundle: 2018 update JO - Intensive Care Med VL - 44 ID - Levy2018 ER - TY - STD TI - Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H, et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT). Eur Respir J. 2017;50(3):1700582. ID - ref2 ER - TY - STD TI - ENVIN - HELICS. Available from: http://hws.vhebron.net/envin-helics/. [cited 2019 Nov 2]. UR - http://hws.vhebron.net/envin-helics/ ID - ref3 ER - TY - JOUR AU - Montravers, P. AU - Bassetti, M. PY - 2018 DA - 2018// TI - The ideal patient profile for new beta-lactam/beta-lactamase inhibitors JO - Curr Opin Infect Dis VL - 31 ID - Montravers2018 ER - TY - JOUR AU - Bassetti, M. AU - Righi, E. AU - Vena, A. AU - Graziano, E. AU - Russo, A. AU - Peghin, M. PY - 2018 DA - 2018// TI - Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug-resistant/extensively drug-resistant/pandrug-resistant bacteria JO - Curr Opin Crit Care VL - 24 ID - Bassetti2018 ER - TY - JOUR AU - Rodríguez-Baño, J. AU - Paño-Pardo, J. R. AU - Alvarez-Rocha, L. AU - Asensio, A. AU - Calbo, E. AU - Cercenado, E. PY - 2012 DA - 2012// TI - Programs for optimizing the use of antibiotics (PROA) in Spanish hospitals: GEIH-SEIMC, SEFH and SEMPSPH consensus document JO - Enferm Infecc Microbiol Clin VL - 30 ID - Rodríguez-Baño2012 ER - TY - JOUR AU - Tabah, A. AU - Cotta, M. O. AU - Garnacho-Montero, J. AU - Schouten, J. AU - Roberts, J. A. AU - Lipman, J. PY - 2016 DA - 2016// TI - A systematic review of the definitions, determinants, and clinical outcomes of antimicrobial de-escalation in the intensive care unit JO - Clin Infect Dis VL - 62 ID - Tabah2016 ER - TY - JOUR AU - Ruiz, J. AU - Ramirez, P. AU - Gordon, M. AU - Villarreal, E. AU - Frasquet, J. AU - Poveda-Andres, J. L. PY - 2018 DA - 2018// TI - Antimicrobial stewardship programme in critical care medicine: a prospective interventional study JO - Med Int VL - 42 ID - Ruiz2018 ER - TY - STD TI - Martin-Loeches I, Povoa P, Nseir S. A way towards ventilator-associated lower respiratory tract infection research. Intensive Care Med. 2020. https://doi.org/10.1007/s00134-020-06101-7 [cited 2020 May 26]. ID - ref9 ER - TY - STD TI - Fernando SM, Tran A, Cheng W, Klompas M, Kyeremanteng K, Mehta S, et al. Diagnosis of ventilator-associated pneumonia in critically ill adult patients—a systematic review and meta-analysis. Intensive Care Med. 2020. https://doi.org/10.1007/s00134-020-06036-z [cited 2020 May 26]. ID - ref10 ER - TY - JOUR AU - Vincent, J. -. L. AU - Rello, J. AU - Marshall, J. AU - Silva, E. AU - Anzueto, A. AU - Martin, C. D. PY - 2009 DA - 2009// TI - International study of the prevalence and outcomes of infection in intensive care units JO - JAMA. VL - 302 ID - Vincent2009 ER - TY - JOUR AU - Magill, S. S. AU - Edwards, J. R. AU - Fridkin, S. K. PY - 2014 DA - 2014// TI - Emerging infections program healthcare-associated infections and antimicrobial use prevalence survey team. Survey of health care-associated infections JO - N Engl J Med VL - 370 ID - Magill2014 ER - TY - JOUR PY - 2005 DA - 2005// TI - Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia JO - Am J Respir Crit Care Med VL - 171 ID - ref13 ER - TY - JOUR AU - Forel, J. -. M. AU - Voillet, F. AU - Pulina, D. AU - Gacouin, A. AU - Perrin, G. AU - Barrau, K. PY - 2012 DA - 2012// TI - Ventilator-associated pneumonia and ICU mortality in severe ARDS patients ventilated according to a lung-protective strategy JO - Crit Care Lond Engl. VL - 16 ID - Forel2012 ER - TY - JOUR AU - Asehnoune, K. AU - Seguin, P. AU - Allary, J. AU - Feuillet, F. AU - Lasocki, S. AU - Cook, F. PY - 2014 DA - 2014// TI - Hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): a double-blind, multicentre phase 3, randomised placebo-controlled trial JO - Lancet Respir Med VL - 2 ID - Asehnoune2014 ER - TY - JOUR AU - Bouglé, A. AU - Bombled, C. AU - Margetis, D. AU - Lebreton, G. AU - Vidal, C. AU - Coroir, M. PY - 2018 DA - 2018// TI - Ventilator-associated pneumonia in patients assisted by veno-arterial extracorporeal membrane oxygenation support: epidemiology and risk factors of treatment failure JO - PLoS One VL - 13 ID - Bouglé2018 ER - TY - JOUR AU - Dudeck, M. A. AU - Weiner, L. M. AU - Allen-Bridson, K. AU - Malpiedi, P. J. AU - Peterson, K. D. AU - Pollock, D. A. PY - 2013 DA - 2013// TI - National Healthcare Safety Network (NHSN) report, data summary for 2012, device-associated module JO - Am J Infect Control VL - 41 ID - Dudeck2013 ER - TY - STD TI - Healthcare-associated infections in intensive care units - Annual Epidemiological Report for 2016. European Centre for Disease Prevention and Control. 2018. Available from: https://www.ecdc.europa.eu/en/publications-data/healthcare-associated-infections-intensive-care-units-annual-epidemiological-0. [cited 2019 Oct 24]. UR - https://www.ecdc.europa.eu/en/publications-data/healthcare-associated-infections-intensive-care-units-annual-epidemiological-0 ID - ref18 ER - TY - STD TI - Incidence and attributable mortality of healthcare-associated infections in intensive care units in Europe, 2008-2012. European Centre for Disease Prevention and Control. 2018. Available from: https://www.ecdc.europa.eu/en/publications-data/incidence-and-attributable-mortality-healthcare-associated-infections-intensive. [cited 2019 Oct 24]. UR - https://www.ecdc.europa.eu/en/publications-data/incidence-and-attributable-mortality-healthcare-associated-infections-intensive ID - ref19 ER - TY - JOUR AU - Álvarez-Lerma, F. AU - Palomar-Martínez, M. AU - Sánchez-García, M. AU - Martínez-Alonso, M. AU - Álvarez-Rodríguez, J. AU - Lorente, L. PY - 2018 DA - 2018// TI - Prevention of ventilator-associated pneumonia: the multimodal approach of the Spanish ICU ‘Pneumonia Zero’ Program JO - Crit Care Med VL - 46 ID - Álvarez-Lerma2018 ER - TY - JOUR AU - Martin-Loeches, I. AU - Povoa, P. AU - Rodríguez, A. AU - Curcio, D. AU - Suarez, D. AU - Mira, J. -. P. PY - 2015 DA - 2015// TI - Incidence and prognosis of ventilator-associated tracheobronchitis (TAVeM): a multicentre, prospective, observational study JO - Lancet Respir Med VL - 3 ID - Martin-Loeches2015 ER - TY - JOUR AU - Nseir, S. AU - Povoa, P. AU - Salluh, J. AU - Rodriguez, A. AU - Martin-Loeches, I. PY - 2016 DA - 2016// TI - Is there a continuum between ventilator-associated tracheobronchitis and ventilator-associated pneumonia? JO - Intensive Care Med VL - 42 ID - Nseir2016 ER - TY - JOUR AU - Keane, S. AU - Martin-Loeches, I. PY - 2019 DA - 2019// TI - Host-pathogen interaction during mechanical ventilation: systemic or compartmentalized response? JO - Crit Care Lond Engl. VL - 23 ID - Keane2019 ER - TY - JOUR AU - Esperatti, M. AU - Ferrer, M. AU - Theessen, A. AU - Liapikou, A. AU - Valencia, M. AU - Saucedo, L. M. PY - 2010 DA - 2010// TI - Nosocomial pneumonia in the intensive care unit acquired by mechanically ventilated versus nonventilated patients JO - Am J Respir Crit Care Med VL - 182 ID - Esperatti2010 ER - TY - JOUR AU - Kohlenberg, A. AU - Schwab, F. AU - Behnke, M. AU - Geffers, C. AU - Gastmeier, P. PY - 2010 DA - 2010// TI - Pneumonia associated with invasive and noninvasive ventilation: an analysis of the German nosocomial infection surveillance system database JO - Intensive Care Med VL - 36 ID - Kohlenberg2010 ER - TY - STD TI - Walter J, Haller S, Quinten C, Kärki T, Zacher B, Eckmanns T, et al. Healthcare-associated pneumonia in acute care hospitals in European Union/European Economic Area countries: an analysis of data from a point prevalence survey, 2011 to 2012. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2018;23(32):1700843. ID - ref26 ER - TY - JOUR AU - Giuliano, K. K. AU - Baker, D. AU - Quinn, B. PY - 2018 DA - 2018// TI - The epidemiology of nonventilator hospital-acquired pneumonia in the United States JO - Am J Infect Control VL - 46 ID - Giuliano2018 ER - TY - JOUR AU - Sopena, N. AU - Sabrià, M. PY - 2005 DA - 2005// TI - Multicenter study of hospital-acquired pneumonia in non-ICU patients JO - Chest. VL - 127 ID - Sopena2005 ER - TY - JOUR AU - Koulenti, D. AU - Tsigou, E. AU - Rello, J. PY - 2017 DA - 2017// TI - Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP/CAP study JO - Eur J Clin Microbiol Infect Dis VL - 36 ID - Koulenti2017 ER - TY - JOUR AU - Ferrer, M. AU - Liapikou, A. AU - Valencia, M. AU - Esperatti, M. AU - Theessen, A. AU - Antonio Martinez, J. PY - 2010 DA - 2010// TI - Validation of the American Thoracic Society-Infectious Diseases Society of America guidelines for hospital-acquired pneumonia in the intensive care unit JO - Clin Infect Dis VL - 50 ID - Ferrer2010 ER - TY - JOUR AU - Restrepo, M. I. AU - Peterson, J. AU - Fernandez, J. F. AU - Qin, Z. AU - Fisher, A. C. AU - Nicholson, S. C. PY - 2013 DA - 2013// TI - Comparison of the bacterial etiology of early-onset and late-onset ventilator-associated pneumonia in subjects enrolled in 2 large clinical studies JO - Respir Care VL - 58 ID - Restrepo2013 ER - TY - JOUR AU - Quartin, A. A. AU - Scerpella, E. G. AU - Puttagunta, S. AU - Kett, D. H. PY - 2013 DA - 2013// TI - A comparison of microbiology and demographics among patients with healthcare-associated, hospital-acquired, and ventilator-associated pneumonia: a retrospective analysis of 1184 patients from a large, international study JO - BMC Infect Dis VL - 13 ID - Quartin2013 ER - TY - JOUR AU - Nseir, S. AU - Martin-Loeches, I. AU - Makris, D. AU - Jaillette, E. AU - Karvouniaris, M. AU - Valles, J. PY - 2014 DA - 2014// TI - Impact of appropriate antimicrobial treatment on transition from ventilator-associated tracheobronchitis to ventilator-associated pneumonia JO - Crit Care Lond Engl. VL - 18 ID - Nseir2014 ER - TY - JOUR AU - Pulido, M. R. AU - Moreno-Martínez, P. AU - González-Galán, V. AU - Fernández Cuenca, F. AU - Pascual, Á. AU - Garnacho-Montero, J. PY - 2018 DA - 2018// TI - Application of BioFire FilmArray Blood Culture Identification panel for rapid identification of the causative agents of ventilator-associated pneumonia JO - Clin Microbiol Infect VL - 24 ID - Pulido2018 ER - TY - JOUR AU - Huang, Y. AU - Jiao, Y. AU - Zhang, J. AU - Xu, J. AU - Cheng, Q. AU - Li, Y. PY - 2018 DA - 2018// TI - Microbial etiology and prognostic factors of ventilator-associated pneumonia: a multicenter retrospective study in Shanghai JO - Clin Infect Dis VL - 67 ID - Huang2018 ER - TY - JOUR AU - Cantón-Bulnes, M. L. AU - González-García, M. A. AU - García-Sánchez, M. AU - Arenzana-Seisdedos, Á. AU - Garnacho-Montero, J. PY - 2019 DA - 2019// TI - A case-control study on the clinical impact of ventilator associated tracheobronchitis in adult patients who did not develop ventilator associated pneumonia JO - Enferm Infecc Microbiol Clin VL - 37 ID - Cantón-Bulnes2019 ER - TY - JOUR AU - Saied, W. AU - Mourvillier, B. AU - Cohen, Y. AU - Ruckly, S. AU - Reignier, J. AU - Marcotte, G. PY - 2019 DA - 2019// TI - A comparison of the mortality risk associated with ventilator-acquired bacterial pneumonia and nonventilator ICU-acquired bacterial pneumonia JO - Crit Care Med VL - 47 ID - Saied2019 ER - TY - JOUR AU - Micek, S. T. AU - Chew, B. AU - Hampton, N. AU - Kollef, M. H. PY - 2016 DA - 2016// TI - A case-control study assessing the impact of nonventilated hospital-acquired pneumonia on patient outcomes JO - Chest. VL - 150 ID - Micek2016 ER - TY - JOUR AU - Kollef, M. H. AU - Shorr, A. AU - Tabak, Y. P. AU - Gupta, V. AU - Liu, L. Z. AU - Johannes, R. S. PY - 2005 DA - 2005// TI - Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia JO - Chest. VL - 128 ID - Kollef2005 ER - TY - STD TI - Research C for DE and. Hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia: developing drugs for treatment. U.S. Food and Drug Administration. 2019. Available from: http://www.fda.gov/regulatory-information/search-fda-guidance-documents/hospital-acquired-bacterial-pneumonia-and-ventilator-associated-bacterial-pneumonia-developing-drugs. [cited 2019 Oct 24]. UR - http://www.fda.gov/regulatory-information/search-fda-guidance-documents/hospital-acquired-bacterial-pneumonia-and-ventilator-associated-bacterial-pneumonia-developing-drugs ID - ref40 ER - TY - JOUR AU - Kollef, M. H. AU - Hamilton, C. W. AU - Ernst, F. R. PY - 2012 DA - 2012// TI - Economic impact of ventilator-associated pneumonia in a large matched cohort JO - Infect Control Hosp Epidemiol VL - 33 ID - Kollef2012 ER - TY - JOUR AU - Micek, S. T. AU - Wunderink, R. G. AU - Kollef, M. H. AU - Chen, C. AU - Rello, J. AU - Chastre, J. PY - 2015 DA - 2015// TI - An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance JO - Crit Care Lond Engl VL - 19 ID - Micek2015 ER - TY - JOUR AU - Melsen, W. G. AU - Rovers, M. M. AU - Groenwold, R. H. H. AU - Bergmans, D. C. J. J. AU - Camus, C. AU - Bauer, T. T. PY - 2013 DA - 2013// TI - Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies JO - Lancet Infect Dis VL - 13 ID - Melsen2013 ER - TY - JOUR AU - Nseir, S. AU - Pompeo, C. AU - Pronnier, P. AU - Beague, S. AU - Onimus, T. AU - Saulnier, F. PY - 2002 DA - 2002// TI - Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome JO - Eur Respir J VL - 20 ID - Nseir2002 ER - TY - STD TI - Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995. Am J Respir Crit Care Med. 1996. 153(5):1711–25. ID - ref45 ER - TY - JOUR AU - Sopena, N. AU - Heras, E. AU - Casas, I. AU - Bechini, J. AU - Guasch, I. AU - Pedro-Botet, M. L. PY - 2014 DA - 2014// TI - Risk factors for hospital-acquired pneumonia outside the intensive care unit: a case-control study JO - Am J Infect Control VL - 42 ID - Sopena2014 ER - TY - JOUR AU - Pasquale, M. AU - Aliberti, S. AU - Mantero, M. AU - Bianchini, S. AU - Blasi, F. PY - 2016 DA - 2016// TI - Non-intensive care unit acquired pneumonia: a new clinical entity? JO - Int J Mol Sci VL - 17 ID - Pasquale2016 ER - TY - JOUR AU - Herzig, S. J. AU - Howell, M. D. AU - Ngo, L. H. AU - Marcantonio, E. R. PY - 2009 DA - 2009// TI - Acid-suppressive medication use and the risk for hospital-acquired pneumonia JO - JAMA. VL - 301 ID - Herzig2009 ER - TY - JOUR AU - Zhang, Z. AU - Duan, J. PY - 2015 DA - 2015// TI - Nosocomial pneumonia in non-invasive ventilation patients: incidence, characteristics, and outcomes JO - J Hosp Infect VL - 91 ID - Zhang2015 ER - TY - JOUR AU - Melsen, W. G. AU - Rovers, M. M. AU - Bonten, M. J. M. PY - 2009 DA - 2009// TI - Ventilator-associated pneumonia and mortality: a systematic review of observational studies JO - Crit Care Med VL - 37 ID - Melsen2009 ER - TY - JOUR AU - Bekaert, M. AU - Timsit, J. -. F. AU - Vansteelandt, S. AU - Depuydt, P. AU - Vésin, A. AU - Garrouste-Orgeas, M. PY - 2011 DA - 2011// TI - Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis JO - Am J Respir Crit Care Med VL - 184 ID - Bekaert2011 ER - TY - JOUR AU - Dupont, H. AU - Mentec, H. AU - Sollet, J. P. AU - Bleichner, G. PY - 2001 DA - 2001// TI - Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia JO - Intensive Care Med VL - 27 ID - Dupont2001 ER - TY - JOUR AU - Zilberberg, M. D. AU - Shorr, A. F. AU - Micek, S. T. AU - Vazquez-Guillamet, C. AU - Kollef, M. H. PY - 2014 DA - 2014// TI - Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study JO - Crit Care Lond Engl. VL - 18 ID - Zilberberg2014 ER - TY - JOUR AU - Kollef, M. H. PY - 2003 DA - 2003// TI - Treatment of ventilator-associated pneumonia: get it right from the start JO - Crit Care Med VL - 31 ID - Kollef2003 ER - TY - JOUR AU - Ranzani, O. T. AU - Ferrer, M. AU - Esperatti, M. AU - Giunta, V. AU - Bassi, G. L. AU - Carvalho, C. R. R. PY - 2012 DA - 2012// TI - Association between systemic corticosteroids and outcomes of intensive care unit-acquired pneumonia JO - Crit Care Med VL - 40 ID - Ranzani2012 ER - TY - STD TI - Ceccato A, Panagiotarakou M, Ranzani OT, Martin-Fernandez M, Almansa-Mora R, Gabarrus A, et al. Lymphocytopenia as a predictor of mortality in patients with ICU-acquired pneumonia. J Clin Med 2019 13;8(6):843. ID - ref56 ER - TY - JOUR AU - Esperatti, M. AU - Ferrer, M. AU - Giunta, V. AU - Ranzani, O. T. AU - Saucedo, L. M. AU - Li Bassi, G. PY - 2013 DA - 2013// TI - Validation of predictors of adverse outcomes in hospital-acquired pneumonia in the ICU JO - Crit Care Med VL - 41 ID - Esperatti2013 ER - TY - JOUR AU - Póvoa, P. AU - Martin-Loeches, I. AU - Ramirez, P. AU - Bos, L. D. AU - Esperatti, M. AU - Silvestre, J. PY - 2017 DA - 2017// TI - Biomarkers kinetics in the assessment of ventilator-associated pneumonia response to antibiotics - results from the BioVAP study JO - J Crit Care VL - 41 ID - Póvoa2017 ER - TY - JOUR AU - Beardsley, J. R. AU - Williamson, J. C. AU - Johnson, J. W. AU - Ohl, C. A. AU - Karchmer, T. B. AU - Bowton, D. L. PY - 2006 DA - 2006// TI - Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia JO - Chest. VL - 130 ID - Beardsley2006 ER - TY - JOUR AU - Bonten, M. J. AU - Weinstein, R. A. PY - 1996 DA - 1996// TI - The role of colonization in the pathogenesis of nosocomial infections JO - Infect Control Hosp Epidemiol VL - 17 ID - Bonten1996 ER - TY - JOUR AU - Torre-Cisneros, J. AU - Natera, C. AU - Mesa, F. AU - Trikic, M. AU - Rodríguez-Baño, J. PY - 2018 DA - 2018// TI - Clinical predictors of methicillin-resistant Staphylococcus aureus in nosocomial and healthcare-associated pneumonia: a multicenter, matched case-control study JO - Eur J Clin Microbiol Infect Dis VL - 37 ID - Torre-Cisneros2018 ER - TY - JOUR AU - Torre-Cisneros, J. AU - Tejero García, R. AU - Natera Kindelán, C. AU - Font Ugalde, P. AU - Franco Álvarez de Luna, F. AU - Castón Osorio, J. J. PY - 2012 DA - 2012// TI - Risk factors of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus JO - Med Clin (Barc) VL - 138 ID - Torre-Cisneros2012 ER - TY - JOUR AU - Metersky, M. L. AU - Frei, C. R. AU - Mortensen, E. M. PY - 2016 DA - 2016// TI - Predictors of Pseudomonas and methicillin-resistant Staphylococcus aureus in hospitalized patients with healthcare-associated pneumonia JO - Respirol Carlton Vic VL - 21 ID - Metersky2016 ER - TY - JOUR AU - Buhl, M. AU - Peter, S. AU - Willmann, M. PY - 2015 DA - 2015// TI - Prevalence and risk factors associated with colonization and infection of extensively drug-resistant Pseudomonas aeruginosa: a systematic review JO - Expert Rev Anti-Infect Ther VL - 13 ID - Buhl2015 ER - TY - JOUR AU - Fernández-Barat, L. AU - Ferrer, M. AU - Rosa, F. AU - Gabarrús, A. AU - Esperatti, M. AU - Terraneo, S. PY - 2017 DA - 2017// TI - Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance JO - J Inf Secur VL - 74 ID - Fernández-Barat2017 ER - TY - JOUR AU - Rojo, V. AU - Vázquez, P. AU - Reyes, S. AU - Puente Fuertes, L. AU - Cervero, M. PY - 2018 DA - 2018// TI - Risk factors and clinical evolution of carbapenemase-producing Klebsiella pneumoniae infections in a university hospital in Spain. Case-control study JO - Rev Espanola Quimioter VL - 31 ID - Rojo2018 ER - TY - JOUR AU - Wang, Z. AU - Qin, R. -. R. AU - Huang, L. AU - Sun, L. -. Y. PY - 2018 DA - 2018// TI - Risk factors for carbapenem-resistant Klebsiella pneumoniae infection and mortality of Klebsiella pneumoniae infection JO - Chin Med J VL - 131 ID - Wang2018 ER - TY - JOUR AU - Gao, B. AU - Li, X. AU - Yang, F. AU - Chen, W. AU - Zhao, Y. AU - Bai, G. PY - 2019 DA - 2019// TI - Molecular epidemiology and risk factors of ventilator-associated pneumonia infection caused by carbapenem-resistant Enterobacteriaceae JO - Front Pharmacol VL - 10 ID - Gao2019 ER - TY - JOUR AU - Sbrana, F. AU - Malacarne, P. AU - Bassetti, M. AU - Tascini, C. AU - Vegnuti, L. AU - Della Siega, P. PY - 2016 DA - 2016// TI - Risk factors for ventilator associated pneumonia due to carbapenemase-producing Klebsiella pneumoniae in mechanically ventilated patients with tracheal and rectal colonization JO - Minerva Anestesiol VL - 82 ID - Sbrana2016 ER - TY - JOUR AU - Peralta, G. AU - Sánchez, M. B. AU - Garrido, J. C. AU - Benito, I. AU - Cano, M. E. AU - Martínez-Martínez, L. PY - 2007 DA - 2007// TI - Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia JO - J Antimicrob Chemother VL - 60 ID - Peralta2007 ER - TY - JOUR AU - Aydemir, H. AU - Tuz, H. I. AU - Piskin, N. AU - Celebi, G. AU - Kulah, C. AU - Kokturk, F. PY - 2019 DA - 2019// TI - Risk factors and clinical responses of pneumonia patients with colistin-resistant Acinetobacter baumannii-calcoaceticus JO - World J Clin Cases VL - 7 ID - Aydemir2019 ER - TY - JOUR AU - Zheng, Y. AU - Wan, Y. AU - Zhou, L. AU - Ye, M. AU - Liu, S. AU - Xu, C. PY - 2013 DA - 2013// TI - Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia JO - Am J Infect Control VL - 41 ID - Zheng2013 ER - TY - JOUR AU - Millot, G. AU - Voisin, B. AU - Loiez, C. AU - Wallet, F. AU - Nseir, S. PY - 2017 DA - 2017// TI - The next generation of rapid point-of-care testing identification tools for ventilator-associated pneumonia JO - Ann Transl Med VL - 5 ID - Millot2017 ER - TY - JOUR AU - Clavel, M. AU - Barraud, O. AU - Moucadel, V. AU - Meynier, F. AU - Karam, E. AU - Ploy, M. -. C. PY - 2016 DA - 2016// TI - Molecular quantification of bacteria from respiratory samples in patients with suspected ventilator-associated pneumonia JO - Clin Microbiol Infect VL - 22 ID - Clavel2016 ER - TY - JOUR AU - Teysseyre, L. AU - Ferdynus, C. AU - Miltgen, G. AU - Lair, T. AU - Aujoulat, T. AU - Lugagne, N. PY - 2019 DA - 2019// TI - Derivation and validation of a simple score to predict the presence of bacteria requiring carbapenem treatment in ICU-acquired bloodstream infection and pneumonia: CarbaSCORE JO - Antimicrob Resist Infect Control VL - 8 ID - Teysseyre2019 ER - TY - JOUR AU - Freire, A. T. AU - Melnyk, V. AU - Kim, M. J. AU - Datsenko, O. AU - Dzyublik, O. AU - Glumcher, F. PY - 2010 DA - 2010// TI - Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia JO - Diagn Microbiol Infect Dis VL - 68 ID - Freire2010 ER - TY - JOUR AU - Rubinstein, E. AU - Lalani, T. AU - Corey, G. R. AU - Kanafani, Z. A. AU - Nannini, E. C. AU - Rocha, M. G. PY - 2011 DA - 2011// TI - Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens JO - Clin Infect Dis VL - 52 ID - Rubinstein2011 ER - TY - JOUR AU - Kollef, M. H. AU - Chastre, J. AU - Clavel, M. AU - Restrepo, M. I. AU - Michiels, B. AU - Kaniga, K. PY - 2012 DA - 2012// TI - A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia JO - Crit Care Lond Engl VL - 16 ID - Kollef2012 ER - TY - JOUR AU - Wunderink, R. G. AU - Niederman, M. S. AU - Kollef, M. H. AU - Shorr, A. F. AU - Kunkel, M. J. AU - Baruch, A. PY - 2012 DA - 2012// TI - Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study JO - Clin Infect Dis VL - 54 ID - Wunderink2012 ER - TY - JOUR AU - Ramirez, J. AU - Dartois, N. AU - Gandjini, H. AU - Yan, J. L. AU - Korth-Bradley, J. AU - McGovern, P. C. PY - 2013 DA - 2013// TI - Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem-cilastatin for treatment of hospital-acquired pneumonia JO - Antimicrob Agents Chemother VL - 57 ID - Ramirez2013 ER - TY - JOUR AU - Awad, S. S. AU - Rodriguez, A. H. AU - Chuang, Y. -. C. AU - Marjanek, Z. AU - Pareigis, A. J. AU - Reis, G. PY - 2014 DA - 2014// TI - A phase 3 randomized double-blind comparison of ceftobiprole medocaril versus ceftazidime plus linezolid for the treatment of hospital-acquired pneumonia JO - Clin Infect Dis VL - 59 ID - Awad2014 ER - TY - JOUR AU - Torres, A. AU - Zhong, N. AU - Pachl, J. AU - Timsit, J. -. F. AU - Kollef, M. AU - Chen, Z. PY - 2018 DA - 2018// TI - Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial JO - Lancet Infect Dis VL - 18 ID - Torres2018 ER - TY - STD TI - Kollef MH, Nováček M, Kivistik Ü, Réa-Neto Á, Shime N, Martin-Loeches I, et al. Ceftolozane-tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial. Lancet Infect Dis. 2019;19(12):1299–311. ID - ref83 ER - TY - JOUR AU - Cisneros, J. M. AU - Rosso-Fernández, C. M. AU - Roca-Oporto, C. AU - Pascale, G. AU - Jiménez-Jorge, S. AU - Fernández-Hinojosa, E. PY - 2019 DA - 2019// TI - Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority controlled trial JO - Crit Care Lond Engl. VL - 23 ID - Cisneros2019 ER - TY - JOUR AU - Bassetti, M. AU - Vena, A. AU - Russo, A. AU - Croxatto, A. AU - Calandra, T. AU - Guery, B. PY - 2018 DA - 2018// TI - Rational approach in the management of Pseudomonas aeruginosa infections JO - Curr Opin Infect Dis VL - 31 ID - Bassetti2018 ER - TY - JOUR AU - Mensa, J. AU - Barberán, J. AU - Soriano, A. AU - Llinares, P. AU - Marco, F. AU - Cantón, R. PY - 2018 DA - 2018// TI - Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa: guidelines by the Spanish Society of Chemotherapy JO - Rev Espanola Quimioter VL - 31 ID - Mensa2018 ER - TY - JOUR AU - Bassetti, M. AU - Righi, E. AU - Carnelutti, A. AU - Graziano, E. AU - Russo, A. PY - 2018 DA - 2018// TI - Multidrug-resistant Klebsiella pneumoniae: challenges for treatment, prevention and infection control JO - Expert Rev Anti-Infect Ther VL - 16 ID - Bassetti2018 ER - TY - STD TI - Goodlet KJ, Nicolau DP, Nailor MD. In vitro comparison of ceftolozane-tazobactam to traditional beta-lactams and ceftolozane-tazobactam as an alternative to combination antimicrobial therapy for Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2017;61(12):e01350–17. ID - ref88 ER - TY - JOUR AU - Tumbarello, M. AU - Trecarichi, E. M. AU - Corona, A. AU - Rosa, F. G. AU - Bassetti, M. AU - Mussini, C. PY - 2019 DA - 2019// TI - Efficacy of ceftazidime-avibactam salvage therapy in patients with infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae JO - Clin Infect Dis VL - 68 ID - Tumbarello2019 ER - TY - JOUR AU - Alraddadi, B. M. AU - Saeedi, M. AU - Qutub, M. AU - Alshukairi, A. AU - Hassanien, A. AU - Wali, G. PY - 2019 DA - 2019// TI - Efficacy of ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae JO - BMC Infect Dis VL - 19 ID - Alraddadi2019 ER - TY - STD TI - Marshall S, Hujer AM, Rojas LJ, Papp-Wallace KM, Humphries RM, Spellberg B, et al. Can ceftazidime-avibactam and aztreonam overcome β-lactam resistance conferred by metallo-β-lactamases in Enterobacteriaceae? Antimicrob Agents Chemother. 2017;61(4):e02243–16. ID - ref91 ER - TY - JOUR AU - Harris, P. N. A. AU - Tambyah, P. A. AU - Lye, D. C. AU - Mo, Y. AU - Lee, T. H. AU - Yilmaz, M. PY - 2018 DA - 2018// TI - Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial JO - JAMA VL - 320 ID - Harris2018 ER - TY - STD TI - Wu JY, Srinivas P, Pogue JM. Cefiderocol: a novel agent for the management of multidrug-resistant Gram-negative organisms. Infect Dis Ther. 2020;9(1):17–40. ID - ref93 ER - TY - JOUR AU - Kollef, M. H. AU - Ricard, J. -. D. AU - Roux, D. AU - Francois, B. AU - Ischaki, E. AU - Rozgonyi, Z. PY - 2017 DA - 2017// TI - A randomized trial of the amikacin fosfomycin inhalation system for the adjunctive therapy of Gram-negative ventilator-associated pneumonia: IASIS Trial JO - Chest. VL - 151 ID - Kollef2017 ER - TY - STD TI - Inhaled amikacin solution BAY41-6551 as adjunctive therapy in the treatment of Gram-negative pneumonia - full text view - ClinicalTrials.gov. Available from: https://clinicaltrials.gov/ct2/show/NCT01799993. [cited 2020 May 25]. UR - https://clinicaltrials.gov/ct2/show/NCT01799993 ID - ref95 ER - TY - JOUR AU - Niederman, M. S. PY - 2019 DA - 2019// TI - Adjunctive nebulized antibiotics: what is their place in ICU infections? JO - Front Med VL - 6 ID - Niederman2019 ER - TY - JOUR AU - Bouglé, A. AU - Foucrier, A. AU - Dupont, H. AU - Montravers, P. AU - Ouattara, A. AU - Kalfon, P. PY - 2017 DA - 2017// TI - Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study JO - Trials VL - 18 ID - Bouglé2017 ER -